Did Thomas Kean buy Abbott Laboratories stock?

Common questions

Did Thomas Kean buy Abbott Laboratories stock?

Yes. Thomas Kean disclosed 4 purchases of Abbott Laboratories (ABT) stock between Jul 23, 2024 and Jan 29, 2026, in STOCK Act reports. Added together, the disclosed ranges come to $4K-$60K.

How big were Thomas Kean's Abbott Laboratories trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $4K-$60K.

Did Thomas Kean make these Abbott Laboratories trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Thomas Kean still own Abbott Laboratories stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Thomas Kean report these trades?

The latest filing is dated Feb 19, 2026. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.